Articles On Genetic Technologies (ASX:GTG)
Title | Source | Codes | Date |
---|---|---|---|
Closing Bell: ASX 200 rides Wall Street tailwinds as optimism rises
The ASX200 is riding Wall Street’s coattails today up 044% Nine out of eleven sectors were higher, with real estate leading the charge Technology was a close second with the help of a unicorn takeover bid Wall Street rallied on Friday a... |
Stockhead | GTG | 13 hours ago |
Top 10 at 10: These ASX gold and gas stocks are meteoric on Monday
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 19 hours ago |
Closing Bell: Ragusa Metals leaps 60% on lithium love; local markets follow on first glint of inflation hopes
ASX 200 and small caps rise circa 1% Regional markets jump on strong leads, US inflation data Ragusa Metals: up 60% Local markets took off at the open, feeling a little of the excitement which took hold of Wall Street overnight. The bench... |
Stockhead | GTG | 4 days ago |
Closing Bell: Peregrine soars, Summit slides and the UK is not OK
ASX benchmark ends 0.6% ahead Peregrine’s gold rush slows, but still up more than 85% for the day The UK is looking awesome, if you’re a fan of recessions The ASX has had a pretty stable afternoon today, after the ASX 200 rose to a 0.5% g... |
Stockhead | GTG | 1 week ago |
Closing Bell: Massive gains but Why Now, Not Later?
Small cap index up 3% ASX 200 is up 1% Wall Street jumps as The Fed asks how high The ASX 200 is up 1% and the Emerging Companies (XEC) index is about 3% higher and the wee buy now pay later’s are the heroes of the dish. But first… Over... |
Stockhead | GTG | 2 weeks ago |
Top 10 at 10: The buy now, pay later revival rolls on
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mover... |
Stockhead | GTG | 2 weeks ago |
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs
US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F... |
Stockhead | GTG | 3 weeks ago |
Closing Bell: Small caps jump 1.5% as exciting ideas about energy loom large across the ASX
Benchmark up circa 1%, small caps surge 1.5% Coal miners eclipsed by Whitehaven record profits Kincora Copper finds so much more copper The small cap S&P/ASX Emerging Companies (XEC) index and the benchmark S&P/ASX 200 (XJO) index... |
Stockhead | GTG | 4 weeks ago |
ASX Health Stocks: Ansell commits to net zero by 2040, but says Scope 3 needs more work
Ansell announces net zero commitment by 2040 Emyria extends its library of novel MDMA-like compounds to >125 Genetic Technologies partners with Melbourne based Siles Health Protective personal equipment Ansell (ASX:ANN) has just annou... |
Stockhead | GTG | 4 weeks ago |
Top 10 at 10: Which ASX stocks have started the today with a bang?
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 4 weeks ago |
Closing Bell: ASX coughs up coal-black furballs and Materials stops even pretending to try
Benchmark sags as Materials sector delivers even more tedious disappointment Coal miners hand back yesterday’s gains as investors tire of Chinese whispers Cannabis offers relief for investors and health stocks climb as well. The ASX has e... |
Stockhead | GTG | 1 month ago |
ASX Health Stocks: Another Aussie biotech gets attention in the US with a pending patent
Cynata receives notice from the US Patent Office GTG completes acquisition of AffinityDNA Dental clinic network Pacific Smiles announces earnings guidance Cell therapeutics specialist, Cynata Therapeutics (ASX:CYP), has just received a No... |
Stockhead | GTG | 1 month ago |
Top 10 at 10: Which ASX stocks are doing the heavy lifting today?
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 1 month ago |
Genetic Technologies completes acquisition of AffinityDNA
Genetic Technologies (ASX:GTG) has completed the acquisition of the direct-to-consumer eCommerce business and distribution rights associated with AffinityDNA. |
BiotechDispatch | GTG | 1 month ago |
Closing Bell: Volatile? The ASX 200 has criss-crossed its opening level for the 17th time today. (So that’s a yes)
The ASX 200 ends ever so slightly up, XEC finds 0.4% Gains in consumer discretionary, tech offset big losses for energy, resources, materials. South Korea, Kiwi’s lift rates ahead of tonight’s US CPI read Investors are facing crunch time... |
Stockhead | GTG | 1 month ago |
Top 10 at 10: Which ASX stocks are floating and falling today?
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 1 month ago |
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit
A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m... |
Stockhead | GTG | 1 month ago |
Genetic Technologies (ASX:GTG) expands EasyDNA into Indian and European markets
Genetic Technologies (GTG) embarks on a significant expansion of its recent acquisition of EasyDNA in both its test portfolio and geographical reach EasyDNA had expanded the availability of its carrier testing and non-invasive prenatal tes... |
themarketherald.com.au | GTG | 1 month ago |
Closing Bell: Australia lifts small cap rate by 2%
Small Caps, ASX 200 accelerate after RBA rate call Cash rate to 1.35%, Capital Economics says 3.5% the target EasyDNA rocks GTG world Forget the RBA, it’s small cap day at Stockhead as the Little Legends index ignores war, floods, flu,... |
Stockhead | GTG | 1 month ago |
ASX Health Stocks: US patent another Prescient win for booming Aussie biotechs
Prescient gets US patent approval Genetic Technologies expands EasyDNA into India and Europe Imricor submits cardiac ablation catheter for EU market Clinical stage oncology company Prescient Therapeutics (ASX: PTX) has been granted a US p... |
Stockhead | GTG | 1 month ago |
Top 10 at 10: Tuesday’s top dogs in early trade
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 1 month ago |
Closing Bell: A little Monday magic ahead of a Tuesday cash rate reality check
The ASX 200 and XEC small cap indices rise Attention turns to Tuesday’s date with RBA destiny Celsius Resources is hot The ASX 200 and the Emerging Markets (XEC) indices are both trading higher on Monday up about 1.2%, ahead of tomorrow... |
Stockhead | GTG | 1 month ago |
ASX Small Cap June Winners: PayGroup pops 164pc on unicorn interest, resources players end on a high
Literally every sector had a red month, but mining was the worst PayGroup gets surprise $120m takeover offer from US unicorn Deel Tempest Minerals signed JV to explore near the Karara Magnetite Iron mine June was a month of global econom... |
Stockhead | GTG | 1 month ago |
Top 10 at 10: These ASX hearing aid, boat building stocks are up and about in early trade
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 1 month ago |
Top 10 at 10: Which ASX stocks are high on hump day?
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 1 month ago |
Closing Bell: Nothing crypto in small caps commodity crunch
Emerging Companies (XEC) index dives 2.6% Benchmark ASX200 down 0.6% Culpeo Minerals meets copper, shares up 70% Aussie small caps have copped a commodities shellacking to start the week as materials, metals and energy stocks bear the... |
Stockhead | GTG | 1 month ago |
ASX Health Stocks: Proteomics proves it can manufacture at scale, GTG sees pathway to the US
Proteomics has completed a manufacturing technology transfer of its PromarkerD test Genetic Technologies build model that could create pathway in the US Proteomics proves it can produce the PromarkerD tests at scale Proteomics Internation... |
Stockhead | GTG | 1 month ago |
Genetic Technologies says modelling demonstrates benefit of new test
Genetic Technologies (ASX:GTG) has completed an independently developed and validated customisable Budget Impact Model that it says demonstrates significant health and economic benefits directly attributed to the implementation of g... |
BiotechDispatch | GTG | 1 month ago |
Closing Bell: Weak leads, weak banks, a one month low and not enough energy to go round
Benchmark and small cap index down hard Life on the indices can be hard, unless your in energy, possibly materials Pearl Gull Iron is an island, literally and figuratively The ASX200 and its emerging companies sidekick have retreated in... |
Stockhead | GTG | 2 months ago |
Closing Bell: Galileo digging all the right holes today; big miners, not so much
Both ASX Small Cap and benchmark index are down about 0.5% A bleak forecast from Covid-stricken China hits resources stocks Appen in trading halt after jumping 30% Local markets took a turn for the worse on Thursday after Chinese Prem... |
Stockhead | GTG | 2 months ago |
Closing Bell: Tech on sale as risk assets start to look a lot like riskier assets
Aussie small cap index falls flat, day two The ASX200 up 0.65% Conico is 50% higher Rising gold prices and teetering tech stocks are playing dice for the soul of the ASX Emerging Companies (XEC) index on Wednesday, as the small cap top... |
Stockhead | GTG | 2 months ago |
Top 10 at 10: These ASX stocks are on a tear in early trade
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 2 months ago |
Closing Bell: It’s a Wednesday feast on the ASX and small caps are the hero of the dish
ASX Small Cap index pops 1.4% rather nicely The top 200 ahead 1% AnteoTech and some clever diggers the big winners on Wednesday The local small cap index is riding a mid-week mining boom with some standout individual performances from... |
Stockhead | GTG | 2 months ago |
Top 10 at 10: These ASX health and exploration stocks are top of the pile today
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 2 months ago |
Genetic Technologies (ASX:GTG) to acquire AffinityDNA for just under $1m
Genetic Technologies (GTG) inks a deal to buy UK-based DNA testing company AffinityDNA for £555,000 (A$985,000) GTG will pay 50 per cent of the cost paid upfront, with the remaining 50 per cent to be paid a year after subject to the financ... |
themarketherald.com.au | GTG | 2 months ago |
ASX Health Stocks: GTG set to jump into online after buying ecommerce outfit AffinityDNA
Genetic Technologies buys out ecommerce company, AffinityDNA Regis Healthcare says it expects to be fully reimbursed by the government for its COVID-19 costs of $14m 4D Medical presents study data at renowned conference Genetic Tech buys... |
Stockhead | GTG | 2 months ago |
Top 10 at 10: The ASX stocks surfing and sinking today
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 3 months ago |
Top 10 at 10: These ASX biotech, helium stocks are rebounding in early trade
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 3 months ago |
Top 10 at 10: These ASX stocks hit the bourse with a bang today
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 3 months ago |
Top 10 at 10: These ASX stocks are ending the month on a high
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 3 months ago |
Closing Bell: Small caps flat, benchmark rises on resurgent resources
The S&P/ASX 200 reclaimed more than 1% in Thursday trade after copping a straight hat-trick of losses. The major energy names and big Papa miners like Rio, Fortescue and BHP climbing strongly after falling even more strongly these last... |
Stockhead | GTG | 3 months ago |
Check Up: Money managers are still bullish on Healthcare; here’s what they said
The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week Dr Anthony Faucci, America’s top infectious disea... |
Stockhead | GTG | 3 months ago |
Closing Bell: A fintech flyer as the ASX follows Wall Street into the red on Friday
The ASX will head into the Anzac day long weekend on a slightly sour note following a Friday selloff. For the microcap Emerging Companies index, it was a ~1.5% fall on the day — but that didn’t stop another triple-digit percentage return, t... |
Stockhead | GTG | 3 months ago |
Top 10 at 10: These ASX stocks have plenty of admirers this morning
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 3 months ago |
Check Up: Biotechs are going through a rough patch, but recent ASX IPOs haven’t flopped too badly
The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot... |
Stockhead | GTG | 4 months ago |
Closing Bell: Small caps go full Maximus, unleash gains in face of rising broad-based fears
Okay, who poked the S&P/ASX Emerging Companies index (XEC) this morning? Someone woke the sleeping Spinosaurus – the largest carnivorous dinosaur on this planet – that lies at the heart of our beloved small cap thermometer. It started r... |
Stockhead | GTG | 4 months ago |
Closing Bell: Small caps, all caps down; Block suffers After pain and China hurts
With Tuesday trade in the casket, the ASX Emerging Companies (XEC) index has closed about 1% lower, while the ASX 200 (XJO) benchmark index is down 0.5%, Everywhere markets fell, but for Paris, which has breathed a rich, garlic-scented merd... |
Stockhead | GTG | 4 months ago |
Closing Bell: Good Friday is coming, let’s hope it makes up for Bad Monday
It’s been an emotional ride for fans of the ASX200 (XJO) which, alongside the Emerging Companies (XEC) index, (down 0.6%) gave up its early gains in a topsy-turvy Monday session. Just after the close, the XJO was weepingly flat – well, up 0... |
Stockhead | GTG | 4 months ago |
Top 10 at 10: These ASX semiconductor, exploration stocks are outshining the rest
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 4 months ago |
Closing Bell: International Graphite climbs 97.5% in its first session, all else is dust
The ASX lost ground on Thursday. Weak leads out of Wall Street, more threats of Western-led sanctions v. Russia and a more hawkish tone out of the Federal Reserve left the benchmark 0.6% down with a half hour before the closing bell. Follow... |
Stockhead | GTG | 4 months ago |